Cite

HARVARD Citation

    Cao, J. et al. (2017). Phase I Dose‐Escalation Study of Ramucirumab in Chinese Patients with Advanced Solid Tumors. Oncologist. pp. 638-e56. [Online]. 
  
Back to record